IL48617A0 - 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them - Google Patents
11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing themInfo
- Publication number
- IL48617A0 IL48617A0 IL48617A IL4861775A IL48617A0 IL 48617 A0 IL48617 A0 IL 48617A0 IL 48617 A IL48617 A IL 48617A IL 4861775 A IL4861775 A IL 4861775A IL 48617 A0 IL48617 A0 IL 48617A0
- Authority
- IL
- Israel
- Prior art keywords
- pentanorprostaglandins
- desoxy
- omega
- substituted
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53167674A | 1974-12-11 | 1974-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL48617A0 true IL48617A0 (en) | 1976-02-29 |
Family
ID=24118594
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL48617A IL48617A0 (en) | 1974-12-11 | 1975-12-08 | 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them |
| IL56863A IL56863A0 (en) | 1974-12-11 | 1979-03-13 | 7-cyclopentyl-heptanoic acid derivatives |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL56863A IL56863A0 (en) | 1974-12-11 | 1979-03-13 | 7-cyclopentyl-heptanoic acid derivatives |
Country Status (21)
| Country | Link |
|---|---|
| JP (3) | JPS51125257A (de) |
| AT (1) | AT351185B (de) |
| BE (1) | BE836564A (de) |
| CH (1) | CH610302A5 (de) |
| CS (3) | CS194733B2 (de) |
| DD (3) | DD129783A5 (de) |
| DE (1) | DE2555210A1 (de) |
| DK (1) | DK559975A (de) |
| ES (1) | ES443421A1 (de) |
| FI (1) | FI753475A (de) |
| FR (1) | FR2293923A1 (de) |
| GB (3) | GB1508170A (de) |
| GR (1) | GR60310B (de) |
| IE (1) | IE43815B1 (de) |
| IL (2) | IL48617A0 (de) |
| LU (1) | LU73997A1 (de) |
| NL (1) | NL166015C (de) |
| NO (1) | NO754195L (de) |
| NZ (1) | NZ179502A (de) |
| SE (1) | SE7513602L (de) |
| ZA (1) | ZA747723B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| US6586468B1 (en) | 1998-09-14 | 2003-07-01 | Ono Pharmaceutical Co., Ltd. | ω-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient |
| US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
| EP2402321A3 (de) * | 2005-12-07 | 2012-02-29 | Ramot at Tel Aviv University, Ltd. | Chemische Derivate aus Jasmonat, pharmazeutische Zusammensetzungen und Verwendungsverfahren dafür |
| US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
| KR102151578B1 (ko) | 2012-07-19 | 2020-09-03 | 카이맨 케미칼 컴파니 인코포레이티드 | Ep4-매개의 골 관련 질병 및 질환을 위한 디플루오로락탐 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES416865A1 (es) * | 1972-07-13 | 1976-03-01 | Pfizer | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. |
-
1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/xx unknown
-
1975
- 1975-11-11 GR GR49337A patent/GR60310B/el unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/xx unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/xx unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/de active Pending
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 DK DK559975A patent/DK559975A/da not_active Application Discontinuation
- 1975-12-10 NZ NZ179502A patent/NZ179502A/xx unknown
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-11 FR FR7537944A patent/FR2293923A1/fr active Granted
- 1975-12-11 AT AT941675A patent/AT351185B/de not_active IP Right Cessation
- 1975-12-11 BE BE1007076A patent/BE836564A/xx not_active IP Right Cessation
- 1975-12-11 JP JP50148319A patent/JPS51125257A/ja active Pending
- 1975-12-11 ES ES443421A patent/ES443421A1/es not_active Expired
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 DD DD7500197925A patent/DD129783A5/de unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/xx not_active IP Right Cessation
- 1975-12-11 CS CS758428A patent/CS194733B2/cs unknown
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 NL NL7514446.A patent/NL166015C/xx not_active IP Right Cessation
- 1975-12-11 DD DD7500197926A patent/DD129649A5/de unknown
- 1975-12-11 CS CS771241A patent/CS194745B2/cs unknown
- 1975-12-11 CS CS771242A patent/CS194746B2/cs unknown
-
1977
- 1977-03-11 JP JP2687477A patent/JPS52102270A/ja active Pending
- 1977-03-11 JP JP2687577A patent/JPS52102258A/ja active Pending
-
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO754195L (de) | 1976-06-14 |
| DD125828A5 (de) | 1977-05-18 |
| GB1508170A (en) | 1978-04-19 |
| DD129783A5 (de) | 1978-02-08 |
| AT351185B (de) | 1979-07-10 |
| CS194745B2 (en) | 1979-12-31 |
| FR2293923B1 (de) | 1979-02-23 |
| IE43815B1 (en) | 1981-06-03 |
| AU8736275A (en) | 1977-10-13 |
| NL166015B (nl) | 1981-01-15 |
| BE836564A (fr) | 1976-06-11 |
| NL166015C (nl) | 1981-06-15 |
| GB1508168A (en) | 1978-04-19 |
| ZA747723B (en) | 1976-11-24 |
| JPS52102270A (en) | 1977-08-27 |
| DD129649A5 (de) | 1978-02-01 |
| CH610302A5 (en) | 1979-04-12 |
| FR2293923A1 (fr) | 1976-07-09 |
| NZ179502A (en) | 1979-01-11 |
| CS194733B2 (en) | 1979-12-31 |
| IL56863A0 (en) | 1979-05-31 |
| GB1508169A (en) | 1978-04-19 |
| JPS52102258A (en) | 1977-08-27 |
| NL7514446A (nl) | 1976-06-15 |
| DE2555210A1 (de) | 1976-06-16 |
| CS194746B2 (en) | 1979-12-31 |
| ES443421A1 (es) | 1977-04-16 |
| SE7513602L (sv) | 1976-06-14 |
| GR60310B (en) | 1978-05-08 |
| FI753475A (de) | 1976-06-12 |
| JPS51125257A (en) | 1976-11-01 |
| IE43815L (en) | 1976-06-11 |
| DK559975A (da) | 1976-06-12 |
| LU73997A1 (de) | 1976-11-11 |
| ATA941675A (de) | 1978-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ179495A (en) | 1-substituted-4-benzylpiperidines and pharmaceutical compositions | |
| KE3052A (en) | Pharmaceutical compositions | |
| IL48637A0 (en) | 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted omega-pentanorprostaglandins and pharmaceutical compositions containing them | |
| IL47625A0 (en) | Novel quinazoline derivatives and pharmaceutical compositions containing them | |
| ZA74385B (en) | Pharmaceutical compositions | |
| ZA755998B (en) | Pharmaceutical compositions | |
| IL47329A (en) | Pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them | |
| IL46965A (en) | Pharmaceutical composition containing heparinoidic factor | |
| JPS51142094A (en) | Iodineecontained product and pharmaceutical composition containing thereof | |
| IL47404A0 (en) | Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them | |
| IL47826A (en) | 7-aminoalkoxy-chroman and-tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| IL48617A0 (en) | 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them | |
| HK17281A (en) | Pharmaceutical compositions | |
| IL48441A (en) | Isoindole derivatives their manufacture and pharmaceutical compositions containing them | |
| NZ179598A (en) | Cephalosporins and pharmaceutical compositions | |
| IL48526A0 (en) | Diaryloxy-imidazolyl-o,n-acetals,their preparation and pharmaceutical compositions containing them | |
| IL47448A0 (en) | Pharmaceutical compositions containing rafoxanide and their use | |
| ZA755802B (en) | Pharmaceutical compositions | |
| IL48309A (en) | 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them | |
| PH11824A (en) | Benzo-naphthyridines and pharmaceutical compositions containing same | |
| CY978A (en) | Pharmaceutical compositions | |
| PH12855A (en) | Pharmaceutical compositions | |
| PH10795A (en) | D-glucose-1-onicotinoyl-2-deoxy-2-nictinkmido derivatives and pharmaceutical composition thereof | |
| NZ178737A (en) | 4a-aryl-trans-decahydroisoquinolines, and pharmaceutical compositions containing such | |
| IL46785A0 (en) | New epoxyalkanes and pharmaceutical compositions containing them |